Recent Videos
Social Wall
Lumryz for Hallucinations in Patients With Narcolepsy
New Data on Pegcetacoplan in Patients With C3G and IC-MPGN
Yuliya Linhares, MD, chief of Lymphoma Services at Miami Cancer Institute, provides an overview of cutaneous T-cell lymphoma #CTCL and discusses some strategies for shortening the diagnostic journey of this rare cancer. #CheckRare #RareDisease
...https://checkrare.com/ctcl-shortening-the-diagnostic-journey-and-starting-treatment-early/
Delpacibart Braxlosiran in Patients With Facioscapulohumeral Muscular Dystrophy
Ibrutinib Plus Venetoclax in Patients With CLL/SLL
First Results From a Study Evaluating CAR-T Cell Therapy for Large B Cell Lymphoma
Larisa Geskin, MD, Columbia University Medical Center, discusses the challenges of diagnosing cutaneous T-cell lymphoma.
#CheckRare #RareDisease #CTCL
https://checkrare.com/ctcl-the-role-of-dermatologists-in-diagnosing-and-caring-for-patients/
Gideon Hirschfield, MD, of the Toronto General Hospital and Toronto Centre for Liver Disease, discusses results from the phase 3 GLISTEN trial in patients with PBC.
https://checkrare.com/phase-3-glisten-trial-in-patients-with-primary-biliary-cholangitis/
#CheckRare #RareDisease ...#PBC #RareAutoimmune #RareGastrointestinal
Learn more about chronic myeloid leukemia (CML) and the current treatment landscape at
https://checkrare.com/chronic-myeloid-leukemia-overview-treatment-options-and-advice/
#CheckRare #RareDisease #CML #RareCancer #RareHematology
💡Rare Disease Spotlight: CIDP
Learn more about this rare disease with our latest article https://checkrare.com/riliprubart-for-the-treatment-of-cidp/
#CheckRare #RareDisease #CIDP #RareAutoimmune #RareNeurology
Cutaneous T-Cell Lymphoma: Quality-of-Life
Cutaneous T-Cell Lymphoma: Management and Treatment
Cutaneous T-Cell Lymphoma: Overview and Diagnosis
Cutaneous T-Cell Lymphoma: Overview, Management, and Quality-of-Life
Results From the CEPHEUS Clinical Trial in Multiple Myeloma
Lumryz for Hallucinations in Patients With Narcolepsy
CheckRare 2 hours ago